EGFR and glioblastoma: Another puzzle in glioblastoma therapeutic development involved the observation that while Epidermal Growth Factor Receptor (EGFR) dysregulation is critically important in the pathogenesis of glioblastomas [4], EGFR inhibitors are clinically ineffective [5].